Inhibition of Clostridium histolyticum supernatant cytotoxic activity by protease inhibitors

Enzyme and Microbial Technology

Volumn 39, Issue 1, 2006, Pages 28-31

  Jóźwiak, Jarosław ^a   Komar, Aldona ^a   Jankowska, Ewa ^a   Martirosian, Gayane ^b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Clostridium histolyticum; Cytotoxicity; Protease inhibitors

Indexed keywords

AMINO ACIDS; CELLS; CYTOLOGY; ENZYME INHIBITION; FLUORIDE MINERALS; HISTOLOGY; TOXICITY;

CLOSTRIDIUM HISTOLYTICUM; CYTOTOXICITY; HISTOLYTICUM SUPERTANANT; PROTEASE INHIBITORS;

ENZYMES;

1 CHLORO 3 (4 TOSYLAMIDO) 7 AMINO 2 HEPTANONE; APROTININ; BENZYLSULFONYL FLUORIDE; CHYMOSTATIN; CLOSTRIPAIN; LEUPEPTIN; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CLOSTRIDIUM HISTOLYTICUM; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG POTENCY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; NONHUMAN; SUPERNATANT;

CLOSTRIDIUM HISTOLYTICUM;

EID: 33646021917     PISSN: 01410229     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.enzmictec.2005.09.002     Document Type: Article

References (27)

1. Durmaz B., Ahel H.E., Sonmez E., Turkoz R., and Aydin E. Infective endocarditis due to Clostridium histolyticum. Clin Microbiol Infect 6 (2000) 561-563
2. Jones J.A., Salmon J.E., and Djuretic D. An outbreak of serious illness and death among injecting drug users in England during. J Med Microbiol 51 (2002) 978-984
3. Brazier J.S., Gai M., and Morris T.E. Outbreak of C. histolyticum infections in injecting drug users in England and Scotland. Eur Surveill 1 (2004) 1-9
4. Yoshida E., and Noda H. Isolation and characterization of collagenases I and II from Clostridium histolyticum. Biochim Biophys Acta 105 (1965) 562-574
5. Sparrow L.G., and McQuade A.B. Isolation by affinity chromatography of neutral protease from Clostridium histolyticum. Biochim Biophys Acta 302 (1973) 90-94
6. Kula M.R., Hatef-Haghi D., Tauber-Finkelstein M., and Shaltiel S. Consecutive use of omega-aminoalkylagaroses. Resolution and purification of clostripain and collagenase from Clostridium histolyticum. Biochem Biophys Res Commun 69 (1976) 389-396
7. Kessler E., and Yaron A. A novel aminopeptidase from Clostridium histolyticum. Biochem Biophys Res Commun 50 (1973) 405-412
8. Moskalewski S., Sochanska K.R., and Wiwatowski T. The presence of a factor toxic to pancreatic beta cells in some collagenase preparations. Bull Acad Pol Sci Biol 22 (1974) 127-130
9. Hefley T., Cushing J., and Brand J.S. Enzymatic isolation of cells from bone: cytotoxic enzymes of bacterial collagenase. Am J Physiol 240 (1981) C234-C238
10. Shemanova G.F., Vlasova E.V., and Shamraeva S.A. Obtaining highly purified preparations of C. histolyticum lethal factor. Vopr Med Khim 14 (1968) 632-635
11. Flick D.A., and Gifford G.E. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J Immunol Methods 68 (1984) 167-175
12. Porter W., Cunningham L., and Mitchell W. Studies on the active site of clostripain. The specific inactivation by the chloromethyl ketone derived from a-N-Tosyl-l-Lysine. J Biol Chem 246 (1971) 7675-7682
13. Park K.B., and Labbe R.G. Proteolysis of Clostridium perfringens type A enterotoxin during purification. Infect Immun 58 (1990) 1999-2001
14. Kassel B. Bovine trypsin-kallikrein inhibitor. Method Enzymol 19 (1970) 844-852
15. Zyznar E.S. A rationale for the application of trasylol as a protease inhibitor in radioimmunoassay. Life Sci 27 (1981) 1861-1866
16. Hewlett G. Apropos aprotinin: a review. Biotechnology (NY) 8 (1990) 565-566 568
17. Gray E.S., and Tsai R.W. Characterization of striped bass growth hormone receptors by disulfide-bond reduction and cross-linking studies. J Exp Zool 268 (1994) 428-435
18. Fischer G. Cultivation of mouse cerebellar cells in serum free, hormonally defined media: survival of neurons. Neurosci Lett 28 (1982) 325-329
19. Lewin M.R., Chowcat N.L., Jayaraj A.P., and Boulos P.B. Collagenase inhibition in colonic mucosa by protease inhibitors. Br J Exp Pathol 67 (1986) 523-526
20. Pellegrini A., Thomas U., Franchini M., Stockli M., Klauser S., Hunziker P., et al. Identification of an aprotinin antiviral domain. FEBS Lett 344 (1994) 261-265
21. Chen R.L., and James R.F. Characterization of an important enzymatic component in collagenase that is essential for the effective digestion of the human and porcine pancreas. Cell Transplant 10 (2001) 709-716
22. Shimizu T., Shima K., Yoshino K., Yonezawa K., Shimizu T., and Hayashi H. Proteome and transcriptome analysis of the virulence genes regulated by the VirR/VirS system in Clostridium perfringens. J Bacteriol 184 (2002) 2587-2594
23. Umezawa H., Aoyagi T., Morishima H., Kunimoto S., and Matsuzaki M. Chymostatin, a new chymotrypsin inhibitor produced by actinomycetes. J Antibiot (Tokyo) 23 (1970) 425-427
24. Fiorentini C., Malorni W., Paradisi S., Giuliano M., Mastrantonio P., and Donelli G. Interaction of Clostridium difficile toxin A with cultured cells: cytoskeletal changes and nuclear polarization. Infect Immun 58 (1990) 2329-2336
25. Florin I., and Thelestam M. Lysosomal involvement in cellular intoxication with Clostridium difficile toxin B. Microb Pathogenesis 1 (1986) 373-385
26. Gilles A., Imhoff J., and Keil B. Chemical chacterization, activity, and thiol content of the highly active form of clostripain. J Biol Chem 254 (1979) 1462-1468
27. Bowen H.E. The partial purification of the lethal toxin of Clostridium histolyticum. Yale J Biol Med 25 (1952) 124-130